We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Case Study · September 07, 2020

Autologous Stem Cell Transplantation After Alemtuzumab in Aggressive MS

Multiple Sclerosis (Houndmills, Basingstoke, England)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
Autologous Hematopoietic Stem Cell Transplantation Following Alemtuzumab Therapy in Aggressive Multiple Sclerosis: A Report of Three Cases
Mult. Scler. 2020 Aug 25;[EPub Ahead of Print], G Boffa, E Sbragia, AM Raiola, R Varaldo, E Capello, P Gallo, F Granella, G Mancardi, M Inglese

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading